KRISTEN STAPLETON: Open Payments
NPI 1932745379 · RICHLANDS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 20 payments from 12 companies in 2025. Trend: 2023 $738 · 2024 $714 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| ABBVIE INC. | 2 | $38 |
| Amgen Inc. | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: Kerendia, CREON, AIRSUPRA, Wegovy, REPATHA, CAPLYTA, Ozempic, LifeVest.
Industry payments across VA — which companies pay providers there.
